Get Started

CABA

NASD Cabaletta Bio, Inc.
Oct 23, 2026 · 9:15 PM ET EOD Market Closed

$1.47 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.47, $0.03 below the day’s high of $1.50

YTD change
-32.88%
vs 20-day SMA
-18.38%
vs 200-day SMA
-48.89%

Price ranges

Previous day
$1.49 $1.56
open $1.53 close $1.52
-$0.01 (-0.65%)
Today
$1.39 $1.50
open $1.50 now $1.47
-$0.03 (-2.00%)
Past week
$1.39 $1.64
from $1.55 now $1.47
-$0.08 (-5.16%)
Past month
$1.39 $2.17
from $2.16 now $1.47
-$0.69 (-31.79%)
This year
$1.39 $4.23
from $2.19 now $1.47
-$0.72 (-32.88%)

Price & Performance

-1.58 (-51.80%) / 6M

$1.19$2.25$3.31$4.37Apr 23Jul 24Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 94.4% away from all-time highs of $26.35
  • CABA is down 33% since the beginning of the year
  • CABA is down 39% over the past 12 months
  • CABA is down 32% over the past 1 month
  • 18% of all CABA investors are betting against CABA

CABA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -39.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.34
Earnings momentum -7.1% Quarterly EPS growth
Quarterly change -7.1%

Valuation

P/E ratio N/A
Enterprise value $30.4M
Beta 3.71

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$225.1M
Debt$25.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $316.9M

Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $439.26 -1.79%
MRNA Moderna, Inc. $200.10 -1.25%
RVMD Revolution Medicines, Inc. $186.99 -0.37%
ROIV Roivant Sciences Ltd. $36.49 -2.56%
BNTX BioNTech SE Sponsored ADR $88.12 -1.73%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.